Ilkka K.
- Country
- Finland
- Department
- A-sairaala AD1/ info
Research Overview
- Evaluation of Venglustat on Neuropathic and Abdominal Pain in Treatment-Naïve or Untreated Fabry Disease Patients Aged ≥16 Years: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- Evaluation of Vicadrostat (BI 690517) and Empagliflozin Efficacy and Safety in Type 2 Diabetes, Hypertension, and Cardiovascular Disease Patients
Data & Insights
Has run more than one trial at 120 of 566 partner sites.
Specializations
Metabolic Disorders
This investigator specializes in the study of severe hypertriglyceridemia (SHTG), a serious metabolic condition characterized by abnormally high levels of triglycerides in the blood. Their research focuses on evaluating novel therapeutic approaches for managing this condition.
- Lipid Metabolism Disorders
- Triglyceride Management
- Cardiovascular Risk Factors
Their expertise extends to investigating innovative treatments for patients with severe lipid disorders.
Therapeutic Development
The investigator conducts research in advanced lipid-lowering therapies, with particular attention to examining new pharmaceutical interventions for treating severe hypertriglyceridemia. Their work includes assessment of treatment safety and efficacy in clinical settings.
- Novel Therapeutic Agents
- Treatment Safety Evaluation
- Clinical Efficacy Assessment
Their research encompasses comprehensive evaluation of therapeutic responses in patients with severe metabolic disorders.
Clinical Assessment
The investigator's work involves biomarker analysis and monitoring of treatment outcomes in patients with severe hypertriglyceridemia. They focus on evaluating fasting triglyceride levels and their response to therapeutic interventions.
- Biomarker Monitoring
- Treatment Response Assessment
- Patient Safety Monitoring
Their research methodology includes detailed analysis of metabolic parameters and treatment effectiveness indicators.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.